Privacy Policy

Suven Life Sciences Limited, adopted this Privacy Policy with respect to its collection, use, storage and disclosure of personal information

Introduction

We are committed to protecting the privacy of personal information and to handling the personal information in a responsible manner in accordance with the relevant privacy legislations in the countries of our operations (referred to as privacy legislation).

This Privacy Policy explains how we collect, use and disclose your personal information, how you may access that information and how you may seek the correction of any information. It also explains how you may make a complaint about a breach of privacy legislation.

From time to time we may make changes to our policy, processes and systems in relation to how we handle your personal information. We will update this Privacy Policy to reflect any changes. Those changes will be available on our website.

Application of this policy

This Privacy Policy applies to the SUVN-502 study, posted on this website. Please read this Privacy Policy carefully. This Privacy describes the information we collect and how we keep your personal information secure and confidential.

By providing us your personal information through an online survey through this website or through any others manner, including Personal Health Information, you consent to the collection and use of your personal information for the purpose of evaluating your eligibility to be part of the SUVN-502 study.

Collection

We collect information that is necessary and relevant to providing our core services and products. The information may include your name, contact details, address, date of birth and gender and such collection of information may be over the phone or in writing, in person, or over the internet. This information may be stored on our computer records system and/or in printed records (collectively, the information).

Use & Disclosure

We will treat your personal information as strictly private and confidential. We will only use or disclose it for purposes directly related to our SUVN-502 study or in ways that you would reasonably expect that we may use it in the course of our business.

We do not sell, trade, or otherwise transfer to outside parties your personal information. This does not include trusted third parties who assist us in operating our website, conducting our business, or servicing you, so long as those parties agree to keep this information confidential and the data is used only for the activities we have asked them to perform. We may also release your information when we believe release is appropriate to comply with the law, or protect ours or others rights, property, or safety.

Data Security

We maintain adequate technical and organizational security measures to protect personal data from loss, misuse, and unauthorized access, disclosure, alteration, or destruction.

Access & Corrections

If you believe that the information we have about you is not accurate, complete or up-to-date, we ask that you contact us in writing.

Sharing information with third parties

We may be required to disclose personal information and personal health information to comply with a law or regulation, or in response to a search warrant, subpoena, or court order. In the event that we are legally compelled to disclose your personal information or personal health information to a third party, we will attempt to notify you, unless doing so would violate the law or court order. Disclosures may also be appropriate to protect our legal rights, to protect the security or integrity of the SUVN-502 study website, to take precautions against liability, or during emergencies if physical safety is believed to be at risk. These types of disclosures are unlikely to occur, but we want you to be aware that they are possible.

Complaints

If you have a complaint about the privacy of your personal information, we request that you contact us in writing, by addressing any complaint to the Compliance Officer. Upon receipt of a complaint we will consider the details and attempt to resolve it in accordance with our complaints handling procedures.

Compliance Officer
K. Hanumanth Rao
Suven Life Sciences Limited
Serene Chambers, Road No. 5, Ave 7
Banjara Hills, Hyderabad 500034, India
Email: khrao@suven.com

Share this Study

If you know someone (family member or friend) who is considering new treatment options for Alzheimer's disease care, they may be interested in the SUVN-502 study.

Share Study